These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 17419418)

  • 1. [Diagnosis and treatment of hyperuricemia and gout].
    Kamatani N
    Nihon Naika Gakkai Zasshi; 2007 Mar; 96(3):510-4. PubMed ID: 17419418
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hyperuricemia/gout].
    Peuke C
    Med Monatsschr Pharm; 2010 Nov; 33(11):429-32. PubMed ID: 21166253
    [No Abstract]   [Full Text] [Related]  

  • 3. [112th Scientific Meeting of the Japanese Society of Internal Medicine: Educational Lecture: Diagnosis and Management of Hyperuricemia and Gout].
    Yamanaka H
    Nihon Naika Gakkai Zasshi; 2015 Sep; 104(9):2039-45. PubMed ID: 30160917
    [No Abstract]   [Full Text] [Related]  

  • 4. [The necessity and importance of standardized diagnosis and treatment of gout].
    Zou HJ
    Zhonghua Nei Ke Za Zhi; 2020 Jun; 59(6):412-413. PubMed ID: 32486578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lesinurad/allopurinol (Duzallo) for gout-associated hyperuricemia.
    Med Lett Drugs Ther; 2017 Nov; 59(1533):182-183. PubMed ID: 29125593
    [No Abstract]   [Full Text] [Related]  

  • 6. Update on gout and hyperuricemia.
    Baker JF; Schumacher HR
    Int J Clin Pract; 2010 Feb; 64(3):371-7. PubMed ID: 19909378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How PCP education can impact gout management: the gout essentials.
    Weaver AL; Cheh MA; Kennison RH
    J Clin Rheumatol; 2008 Oct; 14(5 Suppl):S42-6. PubMed ID: 18830090
    [No Abstract]   [Full Text] [Related]  

  • 8. [Hyperuricemia and gout].
    Gröbner W
    Dtsch Med Wochenschr; 2015 Oct; 140(21):1615-26. PubMed ID: 26488103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hyperuricemia, gout, pseudogout and concomitant diseases].
    Schmidt BM; Wagner AD
    Dtsch Med Wochenschr; 2011 Dec; 136(48):2489-91. PubMed ID: 22109583
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hyperuricemia. When and how to treat?].
    Reuss-Borst MA
    Internist (Berl); 2016 Feb; 57(2):194-201. PubMed ID: 26791735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hyperuricemia and gout: diagnosis and therapy].
    Tausche AK; Unger S; Richter K; Wunderlich C; Grässler J; Roch B; Schröder HE
    Internist (Berl); 2006 May; 47(5):509-20; quiz 521. PubMed ID: 16586130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Why better treatment of gout is needed.
    So AK
    Clin Exp Rheumatol; 2016; 34(4 Suppl 98):63-5. PubMed ID: 27586807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gout: what primary care physicians want to know.
    Dore RK
    J Clin Rheumatol; 2008 Oct; 14(5 Suppl):S47-54. PubMed ID: 18830091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The year in gout: 2011-2012.
    Crittenden DB; Pillinger MH
    Bull NYU Hosp Jt Dis; 2012; 70(3):145-51. PubMed ID: 23259621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hyperuricemia/gout. Main symptoms of arthropathy. Severe acute joint pain, redness, inflammation].
    Kolyvanos Naumann U; Suter PM; Käser L; Vetter W
    Praxis (Bern 1994); 2005 Apr; 94(14):543-8; quiz 549. PubMed ID: 15849976
    [No Abstract]   [Full Text] [Related]  

  • 16. A phase 3, multicenter, randomized, allopurinol-controlled study assessing the safety and efficacy of oral febuxostat in Chinese gout patients with hyperuricemia.
    Xu S; Liu X; Ming J; Chen S; Wang Y; Liu X; Liu H; Peng Y; Wang J; Lin J; Ji H; Liu B; Lu Y; Liu P; Zhang Y; Ji Q
    Int J Rheum Dis; 2015 Jul; 18(6):669-78. PubMed ID: 26013187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An allopurinol-controlled, multicenter, randomized, double-blind, parallel between-group, comparative study of febuxostat in Chinese patients with gout and hyperuricemia.
    Huang X; Du H; Gu J; Zhao D; Jiang L; Li X; Zuo X; Liu Y; Li Z; Li X; Zhu P; Li J; Zhang Z; Huang A; Zhang Y; Bao C
    Int J Rheum Dis; 2014 Jul; 17(6):679-86. PubMed ID: 24467549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of gout and hyperuricemia: Multidisciplinary consensus in Taiwan.
    Yu KH; Chen DY; Chen JH; Chen SY; Chen SM; Cheng TT; Hsieh SC; Hsieh TY; Hsu PF; Kuo CF; Kuo MC; Lam HC; Lee IT; Liang TH; Lin HY; Lin SC; Tsai WP; Tsay GJ; Wei JC; Yang CH; Tsai WC
    Int J Rheum Dis; 2018 Apr; 21(4):772-787. PubMed ID: 29363262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Gout].
    Gröbner W; Zöllner N
    Z Rheumatol; 2004 Feb; 63(1):2-9. PubMed ID: 14991273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "Yellow-dragon Wonderful-seed Formula" for hyperuricemia in gout patients with dampness-heat pouring downward pattern: a pilot randomized controlled trial.
    Yu XN; Wu HY; Deng YP; Zhuang GT; Tan BH; Huang YZ; Tang SY; Tu X; Jordan JB; Zhong S
    Trials; 2018 Oct; 19(1):551. PubMed ID: 30314508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.